Smoking Status Not Associated With TNF Inhibition Discontinuation in axSpA
Researchers examined the effect of smoking on all-cause and cause-specific discontinuation of tumor necrosis factor inhibition in patients with axial spondyloarthritis.
Spondyloarthritis
Incidence Rate of Herpes Zoster Similar in Patients With, Without Ankylosing Spondylitis
The research determines the incidence rate of herpes zoster in patients with AS vs those without AS.
Psoriasis Predicts Entheseal Damage in Axial Spondyloarthritis
The aim was to understand whether psoriasis has disease-modifying effects on disease features and/or severity of enthesitis and spine disease in axSpA.
High Prevalence of Neuropathic-Like Pain in Psoriatic Arthritis
The prevalence of neuropathic-like pain was found to be high in patients with psoriatic arthritis, a condition that may be associated with higher disease activity and fibromyalgia.
Effect of BMI on Response to Abatacept in Psoriatic Arthritis
In a post hoc analysis of the ASTRAEA study, researchers evaluated the effect of BMI on subsequent response to abatacept in psoriatic arthritis.
Main Factors Underlying Fatigue in Psoriatic Arthritis Identified
Inflammation, disease duration, and chronic pain were identified as the main factors underlying fatigue experienced by patients with psoriatic arthritis.
Long-Term Safety of Certolizumab Confirmed for RA, axSpA, PsA
Researchers reviewed the long-term certolizumab safety across all its approved indications, including rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis, and Crohn disease.
Safety Practice Violations Identified in Septic Arthritis Outbreak
Breaches of recommended infection prevention practices have been identified in an outbreak of septic arthritis cases after intra-articular injections performed in a private outpatient facility.
Insulin Resistance May Predict Nonalcoholic Fatty Liver Disease in Psoriasis, Psoriatic Arthritis
A higher prevalence of NAFLD was observed among patients with psoriasis without arthritis compared with patients with psoriatic arthritis.
Achieving ASAS40 Improves Patient-Reported Outcomes in Ankylosing Spondylitis
Patients with ankylosing spondylitis who achieve the ASAS40 end point have less spinal pain at night, less fatigue, better sleep, and improved quality of life.
Next post in Ankylosing Spondylitis
